Vasoactive intestinal polypeptide (VIP) has been demonstrated by immunofluorescence histochemistry in nerves in human and rat penile tissue. A reduction in VIP-like immunoreactivity in nerves was revealed in tissue from streptozotocin-diabetic rats and a human diabetic with impotence. These results suggest that an impairment in the VIP-ergic innervation in penile tissue may be an important factor in the development of impotence in diabetes. They also support the view that the streptozotocin-treated rat is a useful experimental model for diabetic autonomic neuropathy. DIABETES 32:1075-1077, November 1983.
S exual dysfunction is a common complication of diabetes mellitus in men; 12 the prevalence of impotence in diabetic men has been reported to be as high as 50%. 3 Alteration of sexual ability in diabetics may be due to a variety of causes both organic and psychogenic. 4 Neuropathy has been implicated as a factor in the development of organic impotence in some diabetics because neurologic abnormalities have been revealed in the bladder of impotent male diabetics, 5 and it has been reported that impotence is almost inevitable in diabetic men displaying other features of autonomic neuropathy. 6 In a histologic study of post-mortem tissue, morphologic changes have been shown to occur in autonomic nerves of the corpus cavernosum for impotent male diabetics. 7 Vasoactive intestinal polypeptide (VIP) has been demonstrated in nerves in the male and female genito-urinary tract of cats, guinea pigs, and rats, 89 as well as humans. 1011 The present study consists of an investigation of VIP-like immunoreactive nerves of the penis in an animal model of juvenile-onset diabetes produced by treatment of rats with streptozotocin. In order to establish the relevance of the model to the study of diabetic impotence in humans, similar techniques were used on human penile tissue obtained from diabetic and nondiabetic patients suffering from impotence, and the results have been compared.
MATERIALS AND METHODS
Specimens of human penile tissue (both corpus cavernosum and the tunica albuginea) were obtained from an insulindependent diabetic patient and nondiabetic (N = 3) patients undergoing surgery for the implantation of penile prostheses. All the patients were impotent and had impaired nocturnal penile tumescence. The three nondiabetic patients suffered from extensive Peyronie's disease. Penile tissue was dissected from control rats (N = 6) and rats that had been diabetic for 8 wk (N = 8) after intraperitoneal injection of streptozotocin (65 mg/kg; donated by the Division of Cancer Treatment, Institute of Health, Bethesda, Maryland).
Tissue was rapidly fixed in 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS), pH 7.1-7.4, for 2 h at 4°C, rinsed in PBS containing 7% sucrose and 0.01% sodium azide, and left overnight at 4°C in the same buffer. 12 The tissue sections (10 |xm) were cut on a cryostat and immunofluorescence staining was carried out using the indirect method. 13 The sections were incubated for 18 h at room temperature with antisera, raised in rabbits, to VIP [RIA (UK), Newcastle], at a dilution of 1/1000, then rinsed in PBS and incubated for 1 h at room temperature, with fluorescein isothiocyanate conjugated sheep-antirabbit globulin (Miles, Slough, United Kingdom) at a dilution of 1:100. After a further PBS wash, the sections were mounted in PBS/glycerol (1:1) and examined using a Zeiss fluorescence microscope fitted with epi-illumination. Control sections were incubated with either normal rabbit serum or antisera absorbed with VIP as the first layer. 
VIP NEUROPATHY IN THE DIABETIC PENIS OF RAT AND MAN

RESULTS
VIP-like immunoreactive nerves in control rat penis were found predominantly in the erectile (i.e., the corpus cavernosum and corpus spongiosum) and subcutaneous tissue. In these regions, the nerves were found either as single varicose terminal fibers or in bundles and were largely associated with blood vessels. Perivascular VlP-like-immunoreactive nerves were confined to the adventitial-medial border of penile arteries and veins (Figure 1a) .
In the human nondiabetic tissue, VIP-like immunoreactive nerve fibers were found in the erectile tissue of the corpus cavernosum ( Figure 1c ) and on the surface of the tunica albuginea; a few VIP-like immunoreactive nerves were found within the tunica albuginea. In the corpus cavernosum, groups of 3-4 cells (diameter 10-20 |xm), resembling extra adrenal medullary chromaffin cells, also exhibited VIP-like immunoreactivity (Figure 1c insert) . Out of a total of eight streptozotocin-diabetic rats studied, no VIP-like immunoreactive nerves were detected in any region of the penile tissue from four animals. In three diabetic animals, there was a marked reduction in the density of VIPlike immunoreactivity in both perivascular nerves (Figure 1b ) and the nerves in the erectile and subcutaneous tissue. Only in one diabetic rat did the density of VIP-like immunoreactivity in nerves approach that of controls, although some reduction was detectable.
In the penile tissue obtained from the human diabetic with impotence, no VIP-like immunoreactive nerves were detectable either on the surface of, or within, the tunica albuginea. In the corpus cavernosum, very few single varicose fibers were observed, and most of the VIP-like immunohistofluorescence was localized in nerve bundles. There was a marked reduction in the overall density of VIP-like immunoreactivity of these nerves in the diabetic tissue when compared with nondiabetic human penile tissue. Cells exhibiting immunoreactivity to VIP were not observed in the diabetic tissue.
DISCUSSION
Erection of the penis is an active vasomotor reflex phenomenon under the control of two distinct central mechanisms. Psychogenic erections are initiated by supraspinal centers, while reflexogenic erections are mediated by a sacral spinal reflex mechanism.
14 It has been reported that diabetic patients with impotence do not have either psychogenic or reflexogenic erections, 15 and autonomic neuropathy at the peripheral level has been implicated as the main cause. 7 There is evidence to suggest that VIP acts as a neurotransmitter in the male urogenital tract. 16 " 18 VIP-like immunoreactive nerves have been demonstrated in human penile tissue, 11 and the relaxatory effect of VIP may be an essential mechanism in penile erection. 17 Detailed studies of the autonomic innervation of peripheral tissues in clinical diabetes are limited by the lack of availability of suitable control material. This has led to the use of a variety of animal models, including the streptozotocintreated rat, a model of juvenile-onset insulin-dependent diabetes. 19 It is still necessary, however, to establish that changes that occur in the animal model are of relevance to the human diabetic condition. In the present study, it was a consistent finding that the density of VIP-like immunoreactivity was reduced in penile tissue from the streptozotocindiabetic rat when compared with control animals. Similarly a reduction was demonstrated in this preliminary study of the human diabetic penis when compared with nondiabetic human tissue. At this stage it is not possible to conclude whether the reduction in VIP-like immunoreactivity represents a decrease in the total number of VIP-ergic nerves or an alteration in VIP content and/or impairment of antibody binding such that VIP-like immunohistofluoresence is diminished. It should be emphasized that all the human tissue studied here was obtained from patients with impotence. In the nondiabetic patients, however, there was no evidence for any neurologic involvement in their condition. The results reported here provide evidence of a deficit in the VIP-ergic innervation of diabetic penile tissue, which may well play an important part in the development of impotence in diabetes mellitus.
Adrenergic innervation was investigated histochemically in penile tissue from the same rats used in the present study and no evidence was found of decreased histochemical staining for adrenergic nerves in the diabetic penis. Furthermore, no reduction was detectable in the VIP-like immunoreactivity of nerves in sections of the colon and ileum taken at the same time (unpublished observations). Thus, it would appear unlikely that the substantial loss of VIP-like immunoreactivity in the nerves of the diabetic penis reported here represents either a localized toxic effect of streptozotocin on nerves in penile tissue or a general toxic effect of streptozotocin on VIP-ergic nerves. Work is in progress on the ability of insulin to reverse these changes; the results of this study might also contribute to the question of possible toxic effects of streptozotocin.
The fact that streptozotocin-induced diabetes in rats appears to correlate well with human diabetes provides encouraging evidence for its use as an animal model. This model will be used to investigate neuropathic changes in the autonomic innervation of the penis in diabetes, together with the effects of duration of diabetes, insulin treatment, and poor glucose control on the development of such changes.
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